Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pulmonology

Diagnosis and Understanding Your Tests for CTEPH

At a Glance

Diagnosing CTEPH requires a V/Q scan to detect blood flow blockages in the lungs and a right heart catheterization to accurately measure pulmonary blood pressures. A confirmed diagnosis means you have specific physical blockages causing high pressure despite taking blood thinners for three months.

Navigating the diagnosis of CTEPH requires specific tests that go beyond the standard workup for heart or lung issues. To confirm CTEPH, doctors must prove two things: that there are physical blockages in the lung’s arteries, and that these blockages are causing high blood pressure in the lungs—all while the patient has been on blood thinners for at least 3 months [1].

The Gold Standard Screening: The V/Q Scan

While a CT scan is often the first test used when someone has trouble breathing, it is not the best tool for spotting CTEPH. The Ventilation/Perfusion (V/Q) Scan is the preferred initial screening test [2][3].

A V/Q scan compares how air moves in your lungs (ventilation) to how blood flows through them (perfusion). In a patient with CTEPH, the report will often show “mismatched perfusion defects.” This means that while air is reaching certain parts of the lung, the blood flow is blocked by old scar tissue [4][3]. Because V/Q scans are more sensitive than standard CT scans for this specific condition, a “normal” V/Q scan is often enough to rule out CTEPH entirely [5][6].

Confirming the Pressures: Right Heart Catheterization

If your screening tests suggest CTEPH, you will need a Right Heart Catheterization (RHC). This is a procedure where a thin tube (catheter) is guided into a vein, through the right side of your heart, and into the pulmonary arteries to measure pressures and blood flow directly [4].

According to the 2022 ESC/ERS guidelines, a diagnosis of CTEPH is confirmed when the RHC shows these three specific values [1][7]:

  • mPAP (Mean Pulmonary Artery Pressure): Greater than 20 mmHg. (Note: This threshold was lowered from 25 mmHg in 2022 to catch the disease earlier) [7].
  • PAWP (Pulmonary Arterial Wedge Pressure): Less than or equal to 15 mmHg. This ensures the high pressure is coming from the lung’s arteries, not from a problem with the left side of the heart [1].
  • PVR (Pulmonary Vascular Resistance): Greater than 2 Wood units (WU). This measures how much “push back” the heart feels from the lung’s vessels [7].

Seeing the Damage: CTPA and Angiography

Once the high pressure is confirmed, doctors use CT Pulmonary Angiography (CTPA) or Digital Subtraction Angiography (DSA) to map out exactly where the scars are located. These tests look for specific signs of chronic disease, such as “webs” (thin strings of tissue), “bands,” or “eccentric thickening” (narrowing of the vessel walls) [4][8]. These maps are essential for the surgical team to decide if the blockages can be removed.

Your Diagnostic Checklist

To ensure a complete and accurate diagnosis, you should confirm that these steps have been completed:

  1. 3 Months of Anticoagulation: You have been on blood thinners for at least 3 months to see if the clots dissolve naturally [1].
  2. V/Q Scan: To screen for mismatched blood flow defects [2].
  3. Right Heart Catheterization: To get precise pressure measurements (mPAP, PAWP, and PVR) [4].
  4. Advanced Imaging (CTPA/DSA): To visualize the “webs and bands” for treatment planning [4].
  5. Expert Review: Your results should be reviewed by a multidisciplinary team at a specialized CTEPH center [9].

Common questions in this guide

Why is a V/Q scan used instead of a standard CT scan to screen for CTEPH?
A V/Q scan is the preferred screening test because it is highly sensitive at spotting 'mismatched perfusion defects'—areas where air reaches the lungs but blood flow is blocked. Standard CT scans can easily miss these specific types of chronic blockages.
What is the purpose of right heart catheterization for CTEPH?
Right heart catheterization is a procedure that directly measures the blood pressure inside your heart and pulmonary arteries. This test confirms your diagnosis by providing essential measurements, like your mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR).
Why do I need to be on blood thinners for 3 months before being diagnosed?
Doctors require patients to take blood thinners (anticoagulation) for at least three months to see if recent blood clots in the lungs will dissolve on their own. If blockages and high pressure remain after this period, it indicates chronic scar tissue that defines CTEPH.
What do 'webs' or 'bands' mean on my CTEPH imaging report?
Terms like webs, bands, and eccentric thickening describe the specific shapes of chronic scar tissue inside your pulmonary arteries. Doctors use advanced imaging to map these areas and determine if the blockages can be safely removed through surgery.
What is considered a high mPAP level for a CTEPH diagnosis?
According to the latest medical guidelines, a mean pulmonary artery pressure (mPAP) greater than 20 mmHg measured during a right heart catheterization is considered elevated. This helps confirm that your lung pressures are abnormally high.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you confirm that my V/Q scan shows 'mismatched perfusion defects'?
  2. 2.Based on the 2022 ESC/ERS guidelines, does my mPAP of >20 mmHg and PVR of >2 Wood units confirm a CTEPH diagnosis?
  3. 3.If my CTPA was negative but my symptoms persist, can we order a V/Q scan to rule out CTEPH definitively?
  4. 4.During my Right Heart Catheterization, what was my pulmonary arterial wedge pressure (PAWP), and does it rule out left-heart issues?
  5. 5.Do the 'webs' or 'bands' seen on my imaging indicate that my disease is reachable for surgery (PEA)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease: A right heart catheterization study.

    Dhayyat A, Mykland Hilde J, Jervan Ø, et al.

    Pulmonary circulation 2024; (14(4)):e70018 doi:10.1002/pul2.70018.

    PMID: 39654659
  2. 2

    The Role of Lung Ventilation/Perfusion Scan in the Management of Chronic Thromboembolic Pulmonary Hypertension.

    Ha S, Han S

    Nuclear medicine and molecular imaging 2024; (58(7)):449-458 doi:10.1007/s13139-023-00830-5.

    PMID: 39635628
  3. 3

    Chronic Thromboembolic Pulmonary Hypertension: JACC Focus Seminar.

    Papamatheakis DG, Poch DS, Fernandes TM, et al.

    Journal of the American College of Cardiology 2020; (76(18)):2155-2169 doi:10.1016/j.jacc.2020.08.074.

    PMID: 33121723
  4. 4

    Diagnosis of chronic thromboembolic pulmonary hypertension.

    Jais X, Tapson V, Fernandes TM, et al.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2025; (44(7S)):S1-S7 doi:10.1016/j.healun.2025.02.1688.

    PMID: 40653349
  5. 5

    In situ pulmonary arterial thrombosis in pulmonary arterial hypertension: Diagnostic differentiation, imaging criteria, and management-A narrative review with an institutional case-series snapshot.

    Bravo-Vásquez MJ, Cueto-Robledo G, Roldan-Valadez E, et al.

    Current problems in cardiology 2026; (51(1)):103209 doi:10.1016/j.cpcardiol.2025.103209.

    PMID: 41242438
  6. 6

    Editorial Commentary: Chronic thromboembolic pulmonary hypertension evolves diagnostically and therapeutically.

    Luft FC

    Trends in cardiovascular medicine 2017; (27(1)):38-40 doi:10.1016/j.tcm.2016.05.012.

    PMID: 27544725
  7. 7

    Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?

    Cerrone E, Hameed AG, Kiely DG, et al.

    Annals of the American Thoracic Society 2025; (22(3)):331-338 doi:10.1513/AnnalsATS.202405-524OC.

    PMID: 39405159
  8. 8

    The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis.

    Lambert L, Michalek P, Burgetova A

    European radiology 2022; (32(11)):7927-7935 doi:10.1007/s00330-022-08804-5.

    PMID: 35482124
  9. 9

    Chronic thromboembolic pulmonary disease.

    Kim NH, D'Armini AM, Delcroix M, et al.

    The European respiratory journal 2024; (64(4)) doi:10.1183/13993003.01294-2024.

    PMID: 39209473

This page provides educational information about CTEPH diagnostic tests and imaging reports. It is for informational purposes only and does not replace professional medical advice from your pulmonologist, cardiologist, or CTEPH specialist.

Get notified when new evidence is published on Chronic thromboembolic pulmonary hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.